China Biotech Services Holdings Limited (8037.HK)
HKD 0.49
(6.52%)
HKD 0.49
(6.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 211.98 Million | 1.85 Billion | 623.76 Million | 655.79 Million | 59.21 Million | 70.3 Million |
| Cost of Revenue | 177.66 Million | 750.57 Million | 265.74 Million | 316.71 Million | 36.84 Million | 42.22 Million |
| Gross Profit | 34.32 Million | 1.1 Billion | 358.02 Million | 339.08 Million | 22.37 Million | 28.08 Million |
| Operating Expenses | 161.99 Million | 251.52 Million | 168.8 Million | 139.3 Million | 106.43 Million | 95.4 Million |
| Selling, General and Administrative Expenses | 128.96 Million | 254.88 Million | 168.8 Million | 144.33 Million | 106.49 Million | 95.95 Million |
| Research and Development Expenses | 29.04 Million | 27.76 Million | 28.67 Million | 29.19 Million | 10.68 Million | - |
| Other Expenses | 3.98 Million | -3.36 Million | 738 Thousand | -5.03 Million | -57 Thousand | 172 Thousand |
| Cost and Expenses | 339.65 Million | 1 Billion | 434.54 Million | 456.01 Million | 143.27 Million | 137.62 Million |
| Operating Income | -127.67 Million | 851.7 Million | 189.44 Million | 200.6 Million | -84.06 Million | -69.56 Million |
| Interest Expense | 5.31 Million | 3.49 Million | 6.54 Million | 6.49 Million | 1.69 Million | 3.47 Million |
| Income Tax Expense | -1.31 Million | 157.25 Million | 48.09 Million | 35.17 Million | -2.11 Million | 189 Thousand |
| Earnings before Tax | -142.02 Million | 862.82 Million | 180.66 Million | 202.8 Million | -109.59 Million | -69.24 Million |
| Net Income | -95.44 Million | 705.56 Million | 132.57 Million | 167.62 Million | -107.48 Million | -64.25 Million |
| Earnings Per Share Basic | -0.10 | 0.73 | 0.14 | 0.17 | -0.11 | -0.07 |
| Earnings Per Share Diluted | -0.10 | 0.73 | 0.14 | 0.17 | -0.11 | -0.07 |
| Weighted Average Shares Outstanding | 963.23 Million | 963.23 Million | 964.71 Million | 968.49 Million | 960.87 Million | 881.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 963.23 Million | 963.23 Million | 964.71 Million | 968.49 Million | 960.87 Million | 881.71 Million |
| Gross Margin | 0.16 | 0.59 | 0.57 | 0.52 | 0.38 | 0.40 |
| EBIT Margin | -0.35 | 0.49 | 0.41 | 0.37 | -0.96 | -0.84 |
| Profit Margin | -0.45 | 0.38 | 0.21 | 0.26 | -1.82 | -0.91 |
| EBITDA | -73.45 Million | 936.9 Million | 255.32 Million | 249.63 Million | -86.31 Million | -57.52 Million |
| Earnings Before Tax Margin | -0.60 | 0.46 | 0.30 | 0.31 | -1.42 | -0.99 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.22 Million | 16.22 Million | 29.62 Million | 211.98 Million | 18.35 Million | 51.79 Million |
| Cost of Revenue | 17.77 Million | 17.77 Million | 56.63 Million | 177.66 Million | 29.75 Million | 39.63 Million |
| Gross Profit | -1.55 Million | -1.55 Million | -27 Million | 34.32 Million | -11.4 Million | 12.16 Million |
| Operating Expenses | 60.74 Million | 60.74 Million | 72.96 Million | 158 Million | 34.28 Million | 36.59 Million |
| Selling, General and Administrative Expenses | 47.51 Million | 47.51 Million | 72.96 Million | - | 34.29 Million | 36.6 Million |
| Research and Development Expenses | - | - | 29.04 Million | - | - | - |
| Other Expenses | 13.22 Million | 13.22 Million | 126 Thousand | 636 Thousand | 206 Thousand | 174 Thousand |
| Cost and Expenses | 78.51 Million | 78.51 Million | 129.59 Million | 335.67 Million | 64.04 Million | 76.22 Million |
| Operating Income | -62.29 Million | -62.29 Million | -99.96 Million | -123.68 Million | -49.24 Million | -32.97 Million |
| Interest Expense | - | - | 1.37 Million | 5.31 Million | 1.26 Million | 1.31 Million |
| Income Tax Expense | 263.5 Thousand | 263.5 Thousand | -4.36 Million | -1.31 Million | -435 Thousand | -777 Thousand |
| Earnings before Tax | -63.12 Million | -63.12 Million | -112.44 Million | -134.34 Million | -55.41 Million | -20.71 Million |
| Net Income | -39.95 Million | -39.95 Million | -64.96 Million | -95.44 Million | -35.49 Million | -15.1 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.07 | - | -0.04 | -0.02 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.07 | - | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 963.25 Million | 963.25 Million | 963.23 Million | 963.23 Million | 963.23 Million | 963.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 963.23 Million | 963.23 Million | 963.23 Million | 963.23 Million | 963.23 Million | 963.23 Million |
| Gross Margin | -0.10 | -0.10 | -0.91 | 0.16 | -0.62 | 0.23 |
| EBIT Margin | -2.71 | -2.71 | -2.69 | - | -2.96 | -0.66 |
| Profit Margin | -2.46 | -2.46 | -2.19 | -0.45 | -1.93 | -0.29 |
| EBITDA | -43.99 Million | -43.99 Million | -79.73 Million | - | -54.39 Million | -34.25 Million |
| Earnings Before Tax Margin | -3.84 | -3.84 | -3.37 | -0.58 | -2.68 | -0.64 |
060280
VEOEY
JASH
603990
ECLERX
ELIN